Home
About
Publications Trends
Recent Publications
Expert Search
Archive
response rates
What Is Stable Disease?
Stable disease (SD) means that the cancer has neither decreased significantly nor increased in size. This can still be considered a positive outcome if the primary goal is to halt disease progression.
Frequently asked queries:
What Are Response Rates in Cancer Treatment?
How Are Response Rates Measured?
What Is a Partial Response?
What Is Stable Disease?
What Is Progressive Disease?
Why Are Response Rates Important?
What Factors Affect Response Rates?
Are There Limitations to Response Rates?
How Do Response Rates Differ Between Therapies?
What Is the Future of Response Rate Evaluation?
What is the Prognosis for Cancer Patients with Elevated Bilirubin?
How Does Signal Processing Aid in Cancer Detection?
How Does Pericentric Inversion Occur?
How Do I Enroll in Medigap?
What Are Some Preventive Measures?
What Happens if No Attorney in Fact is Designated?
Why is Breast Self-Exam Important?
How is Advanced Melanoma Diagnosed?
What are the safety precautions for cancer patients during treatment?
How Does Module Detection Aid in Cancer Treatment?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Nanotechnology
Non-Hodgkin’s Lymphoma
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
CIAbimatoprost
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
diffuse large B-cell lymphoma
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
Keratinocyte
Lipid-based nanoparticles
liver cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
radiotherapy
refractory lymphoma
relapsed lymphoma
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe